1 조시현, "원발성 복막암의 임상적 고찰" 15 : 107-12, 2004
2 문을주, "상피성 난소암 217예의 임상병리학적 특징과 생존율 분석" 43 : 1604-10, 200
3 서동주, "난소종양의 임상적 고찰 및 예후인자 분석" 대한산부인과학회 47 (47): 1886-1893, 2004
4 Bloss JD, "a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study" 89 : 148-54, 2003
5 Piver MS, "The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma" 6 : 983-9, 1988
6 Eltabbakh GH, "Prognostic factors in extraovarian primary peritoneal carcinoma" 71 : 230-9, 1998
7 Redman JR, "Prognostic factors in advanced ovarian carcinoma" 4 : 515-23, 1986
8 Dubernard G, "Prognosis of stage III or IV primary peritoneal serous papillary carcinoma" 30 : 976-81, 2004
9 Ben-Baruch G, "Primary peritoneal serous papillary carcinoma:a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma" 60 : 393-6, 1996
10 Altaras MM, "Primary peritoneal papillary serous adenocarcinoma:clinical and management aspects" 40 : 230-6, 1991
1 조시현, "원발성 복막암의 임상적 고찰" 15 : 107-12, 2004
2 문을주, "상피성 난소암 217예의 임상병리학적 특징과 생존율 분석" 43 : 1604-10, 200
3 서동주, "난소종양의 임상적 고찰 및 예후인자 분석" 대한산부인과학회 47 (47): 1886-1893, 2004
4 Bloss JD, "a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study" 89 : 148-54, 2003
5 Piver MS, "The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma" 6 : 983-9, 1988
6 Eltabbakh GH, "Prognostic factors in extraovarian primary peritoneal carcinoma" 71 : 230-9, 1998
7 Redman JR, "Prognostic factors in advanced ovarian carcinoma" 4 : 515-23, 1986
8 Dubernard G, "Prognosis of stage III or IV primary peritoneal serous papillary carcinoma" 30 : 976-81, 2004
9 Ben-Baruch G, "Primary peritoneal serous papillary carcinoma:a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma" 60 : 393-6, 1996
10 Altaras MM, "Primary peritoneal papillary serous adenocarcinoma:clinical and management aspects" 40 : 230-6, 1991
11 Chu CS, "Primary peritoneal carcinoma:a review of the literature" 54 : 323-35, 1999
12 Lele SB, "Peritoneal papillary carcinoma" 31 : 315-20, 1988
13 Strnad CM, "Peritoneal carcinomatosis of unknown primary site in women A distinctive subset of adenocarcinoma" 213-7,
14 Ransom DT, "Papillary serous carcinoma of the peritoneum A review of 33 cases treated with platin-based chemotherapy" 66 : 1091-4, 1990
15 Fromm GL, "Papillary serous carcinoma of the peritoneum" 75 : 89-95, 1990
16 Killackey MA, "Papillary serous carcinoma of the peritoneal surface:matched-case comparison with papillary serous ovarian carcinoma" 51 : 171-4, 1993
17 Mulhollan TJ, "Ovarian involvement by serous surface papillary carcinoma" 13 : 120-6, 1994
18 van der Burg ME, "Ovarian cancer:the prognostic value of the serum half-life of CA125 during induction chemotherapy" 30 : 307-12, 1988
19 Cowan LJ, "Extraovarian stage IV peritoneal serous papillary carcinoma presenting as an asymptomatic skin lesion-a case report and literature review" 57 : 433-5, 1995
20 Bloss JD, "Extraovarian peritoneal serous papillary carcinoma:a case-control retrospective comparison to papillary adenocarcinoma of the ovary" 50 : 347-51, 1993
21 Barda G, "Comparison between primary peritoneal and epithelial ovarian carcinoma" 190 : 1039-45, 2004
22 Sevelda P, "CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer" 161 : 1213-6, 1989
23 Dalrymple JC, "A clinicopathologic study of 31 cases" 110-5,
24 Mills SE, "A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma" 827-34, amjsurgpathol1988